Opioid-Related Disorders
"Opioid-Related Disorders" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Disorders related or resulting from abuse or mis-use of opioids.
Descriptor ID |
D009293
|
MeSH Number(s) |
C25.775.675 F03.900.675
|
Concept/Terms |
Opioid-Related Disorders- Opioid-Related Disorders
- Disorder, Opioid-Related
- Opioid Abuse
- Abuse, Opioid
- Abuses, Opioid
- Opioid Abuses
- Opiate Abuse
- Abuse, Opiate
- Abuses, Opiate
- Opiate Abuses
Opiate Dependence- Opiate Dependence
- Dependence, Opiate
- Opiate Addiction
- Addiction, Opiate
|
Below are MeSH descriptors whose meaning is more general than "Opioid-Related Disorders".
Below are MeSH descriptors whose meaning is more specific than "Opioid-Related Disorders".
This graph shows the total number of publications written about "Opioid-Related Disorders" by people in this website by year, and whether "Opioid-Related Disorders" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
Year | Major Topic | Minor Topic | Total |
---|
2002 | 0 | 1 | 1 | 2003 | 0 | 2 | 2 | 2004 | 1 | 1 | 2 | 2005 | 1 | 1 | 2 | 2006 | 2 | 0 | 2 | 2007 | 3 | 3 | 6 | 2008 | 1 | 1 | 2 | 2009 | 2 | 0 | 2 | 2010 | 1 | 0 | 1 | 2011 | 2 | 0 | 2 | 2012 | 2 | 0 | 2 | 2013 | 4 | 1 | 5 | 2014 | 9 | 0 | 9 | 2015 | 7 | 0 | 7 | 2016 | 8 | 2 | 10 | 2017 | 15 | 3 | 18 | 2018 | 17 | 8 | 25 | 2019 | 23 | 6 | 29 | 2020 | 34 | 3 | 37 | 2021 | 28 | 2 | 30 | 2022 | 23 | 0 | 23 |
To return to the timeline, click here.
Below are the most recent publications written about "Opioid-Related Disorders" by people in Profiles.
-
Calcaterra SL, Martin M, Bottner R, Englander H, Weinstein Z, Weimer MB, Lambert E, Herzig SJ. Management of opioid use disorder and associated conditions among hospitalized adults: A Consensus Statement from the Society of Hospital Medicine. J Hosp Med. 2022 09; 17(9):744-756.
-
Calcaterra SL, Bottner R, Martin M, Englander H, Weinstein ZM, Weimer MB, Lambert E, Ronan MV, Huerta S, Zaman T, Ullal M, Peterkin AF, Torres-Lockhart K, Buresh M, O'Brien MT, Snyder H, Herzig SJ. Management of opioid use disorder, opioid withdrawal, and opioid overdose prevention in hospitalized adults: A systematic review of existing guidelines. J Hosp Med. 2022 09; 17(9):679-692.
-
Glanz JM, Binswanger IA, Clarke CL, Nguyen AP, Ford MA, Ray GT, Xu S, Hechter RC, Yarborough BJH, Roblin DW, Ahmedani B, Boscarino JA, Andrade SE, Rosa CL, Campbell CI. The association between buprenorphine treatment duration and mortality: a multi-site cohort study of people who discontinued treatment. Addiction. 2023 Jan; 118(1):97-107.
-
Mutter R, Black J, Iwanicki J. Changes in the Street Prices of Prescription Opioids During the COVID-19 Pandemic. Psychiatr Serv. 2023 Jan 01; 74(1):63-65.
-
Melnick ER, Nath B, Dziura JD, Casey MF, Jeffery MM, Paek H, Soares WE, Hoppe JA, Rajeevan H, Li F, Skains RM, Walter LA, Patel MD, Chari SV, Platts-Mills TF, Hess EP, D'Onofrio G. User centered clinical decision support to implement initiation of buprenorphine for opioid use disorder in the emergency department: EMBED pragmatic cluster randomized controlled trial. BMJ. 2022 06 27; 377:e069271.
-
Chockalingam L, Burnham EL, Jolley SE. Medication prescribing for alcohol use disorders during alcohol-related encounters in a Colorado regional healthcare system. Alcohol Clin Exp Res. 2022 06; 46(6):1094-1102.
-
Szczesniak L, Sullivan R. Microdose Induction of Buprenorphine in a Patient Using Tianeptine. J Addict Med. 2022 Nov-Dec 01; 16(6):736-738.
-
Afshar M, Sharma B, Dligach D, Oguss M, Brown R, Chhabra N, Thompson HM, Markossian T, Joyce C, Churpek MM, Karnik NS. Development and multimodal validation of a substance misuse algorithm for referral to treatment using artificial intelligence (SMART-AI): a retrospective deep learning study. Lancet Digit Health. 2022 06; 4(6):e426-e435.
-
Wachholtz A, Robinson D, Epstein E. Developing a novel treatment for patients with chronic pain and Opioid User Disorder. Subst Abuse Treat Prev Policy. 2022 05 07; 17(1):35.
-
Running Bear U, Hanson JD, Noonan C, Muller C, Trojan J, Manson SM. Factors associated with readmission to alcohol and opioid detoxification in the Alaska Interior. Am J Addict. 2022 Sep; 31(5):406-414.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|